Clinical Trials Browser

NIH × Interventional × Camurati-Engelmann Syndrome × Clear all

NCT04501094 2022-03-22

A Phase II Study of Bintrafusp Alfa (M7824) in Checkpoint Inhibitor Naive and Refractory Subjects With Urothelial Carcinoma

Phase 2 Terminated

2 enrolled 13 charts

Camurati-Engelmann Syndrome

NCT00001378 2008-03-04

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Phase 1 Completed

Breast Neoplasms, Camurati-Engelmann Syndrome